<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1308">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05144126</url>
  </required_header>
  <id_info>
    <org_study_id>21/SP/COM/01</org_study_id>
    <nct_id>NCT05144126</nct_id>
  </id_info>
  <brief_title>Safety, Radiological and Patient Reported Outcomes of i-FACTOR+ Matrix Bone Graft Device - A Canadian, Multicenter, Post-Market Clinical Investigation</brief_title>
  <acronym>CAPREG</acronym>
  <official_title>Safety, Radiological and Patient Reported Outcomes of i-FACTOR+ Matrix Bone Graft Device - A Canadian, Multicenter, Post-Market Clinical Investigation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>CeraPedics, Inc</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Talosix</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Medical Metrics Diagnostics, Inc</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>CeraPedics, Inc</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study intends tracking the usage patterns of a Bonegraft device within spine surgery in a&#xD;
      multicenter setting in Canada.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study wil track the usage patterns of a bone graft by identifying and classifying spine&#xD;
      surgery procedures by access and segment type within the spins and furthet, record and&#xD;
      analyse safety and performance measures associated with each classification. This is a&#xD;
      post-market surveillance study&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 2022</start_date>
  <completion_date type="Anticipated">September 2025</completion_date>
  <primary_completion_date type="Anticipated">May 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>index segment revision</measure>
    <time_frame>12-months post-operative</time_frame>
    <description>Reintervention rate at index segment</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Degenerative Disc Disease</condition>
  <arm_group>
    <arm_group_label>i-Factor Arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All patients undergoing spine fusion surgery will be treated with i-FACTOR</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>CT radioraphic assessment</intervention_name>
    <description>CT radioraphic assessment</description>
    <arm_group_label>i-Factor Arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult patient subjects not responding to conservative management of neck / arm or&#xD;
             back/leg pain and requiring spinal fusion between levels C1 - T2 or L1 - S1&#xD;
&#xD;
          -  Informed Consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Hypersensitivity to i-FACTOR Bone Graft Devices&#xD;
&#xD;
          -  Adult Spinal deformity, Spinal Cord Injury&#xD;
&#xD;
          -  Infection&#xD;
&#xD;
          -  Compromised renal function&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christopher Witiw, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>St Michael's Hosptal Toronto</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Shankar Sivshankar, MS</last_name>
    <phone>+447975566265</phone>
    <email>ssivshankar@cerapedics.com</email>
  </overall_contact>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 21, 2021</study_first_submitted>
  <study_first_submitted_qc>November 21, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 3, 2021</study_first_posted>
  <last_update_submitted>November 21, 2021</last_update_submitted>
  <last_update_submitted_qc>November 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Intervertebral Disc Degeneration</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

